Pediatrics Department, Pediatrics Research Group, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Madrid, Spain.
Pediatric Research and Clinical Trials Unit (UPIC), Pediatrics Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Fundación de Investigación Biomédica Hospital 12 de Octubre, RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
Pediatr Pulmonol. 2022 Oct;57(10):2374-2382. doi: 10.1002/ppul.26042. Epub 2022 Jul 8.
Pneumonia is a frequent manifestation of coronavirus disease 2019 (COVID-19) in hospitalized children.
The study involved 80 hospitals in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spanish Pediatric National Cohort. Participants were children <18 years, hospitalized with SARS-CoV-2 community-acquired pneumonia (CAP). We compared the clinical and radiological characteristics of SARS-CoV-2-associated CAP with CAP due to other viral etiologies from ValsDance (retrospective) cohort.
In total, 151 children with SARS-CoV-2-associated CAP and 138 with other viral CAP were included. Main clinical features of SARS-CoV-2-associated CAP were cough, fever, or dyspnea. Lymphopenia was found in 43% patients and 15% required admission to the pediatric intensive care unit (PICU). Chest X-ray revealed condensation (42%) and other infiltrates (58%). Compared with CAP from other viral pathogens, COVID-19 patients were older, with lower C-reactive protein (CRP) levels, less wheezing, and greater need of mechanical ventilation (MV). There were no differences in the use of continuous positive airway pressure (CPAP) or HVF, or PICU admission between groups.
SARS-CoV-2-associated CAP in children presents differently to other virus-associated CAP: children are older and rarely have wheezing or high CRP levels; they need less oxygen but more CPAP or MV. However, several features overlap and differentiating the etiology may be difficult. The overall prognosis is good.
肺炎是住院儿童中 2019 年冠状病毒病(COVID-19)的常见表现。
该研究涉及严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)西班牙儿科国家队列中的 80 家医院。参与者为<18 岁、因 SARS-CoV-2 社区获得性肺炎(CAP)住院的儿童。我们比较了 SARS-CoV-2 相关 CAP 与其他病毒病因引起的 CAP 在 ValsDance(回顾性)队列中的临床和影像学特征。
共纳入 151 例 SARS-CoV-2 相关 CAP 患儿和 138 例其他病毒 CAP 患儿。SARS-CoV-2 相关 CAP 的主要临床特征为咳嗽、发热或呼吸困难。43%的患者存在淋巴细胞减少症,15%的患者需要入住儿科重症监护病房(PICU)。胸部 X 线显示有冷凝(42%)和其他浸润(58%)。与其他病毒病原体引起的 CAP 相比,COVID-19 患儿年龄较大,C 反应蛋白(CRP)水平较低,喘息较少,更需要机械通气(MV)。两组间 CPAP 或 HVF 的使用或 PICU 入院率无差异。
儿童 SARS-CoV-2 相关 CAP 与其他病毒相关 CAP 的表现不同:儿童年龄较大,很少有喘息或高 CRP 水平;他们需要较少的氧气,但需要更多的 CPAP 或 MV。然而,有几个特征重叠,病因难以区分。总体预后良好。